Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein model
about
Optimization of catheter ablation of atrial fibrillation: insights gained from clinically-derived computer modelsAtrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial ModelsSlow Conduction in the Border Zones of Patchy Fibrosis Stabilizes the Drivers for Atrial Fibrillation: Insights from Multi-Scale Human Atrial Modeling.A new algorithm to diagnose atrial ectopic origin from multi lead ECG systems--insights from 3D virtual human atria and torso.Virtual electrophysiological study of atrial fibrillation in fibrotic remodelingConditions for Waveblock Due to Anisotropy in a Model of Human Ventricular Tissue.Effect of Twisted Fiber Anisotropy in Cardiac Tissue on Ablation with Pulsed Electric Fields.The virtual heart as a platform for screening drug cardiotoxicity.Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesisComputational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation.Novel ion channel targets in atrial fibrillation.Initiation and sustenance of reentry are promoted by two different mechanisms.Electrophysiological Characteristics, Rhythm, Disturbances and Conduction Discontinuities Under Autonomic Stimulation in the Rat Pulmonary Vein Myocardium.Variability in pulmonary vein electrophysiology and fibrosis determines arrhythmia susceptibility and dynamics.Computational cardiac electrophysiology is ready for prime timeComputational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges
P2860
Q28083892-B19C5947-7BAD-4DD7-8335-FC7A4F577E7FQ28555072-1579F617-14C6-4056-8BA2-CD87BDC78350Q30826441-59756DA2-AF01-485A-BA11-B79A1E01608AQ35001458-907508D7-F422-42AE-9524-D0938E254ED6Q35098561-408B5D08-9F13-42DB-8B1F-F3907732EA5BQ35829109-81B84061-66C9-4741-BA8D-651E431D9A7FQ35996216-1224CDAD-8D8D-47D0-AD7A-FB8A5A43E03DQ36342116-D3235D87-D939-48A7-A746-4048CE5BB60EQ36400524-3B854AFC-51CD-4FA8-A0C8-AF5FC72F1018Q36407327-B61AB879-9E06-4070-B350-63E6DBA5432EQ38638006-B09CCE43-39DC-49D2-B6DD-6AF72C9DD39DQ38751315-4A6994CD-4D9C-412F-ADA4-9ADDCFCF5976Q43160012-BA63707D-C6FB-476C-9EA9-96182F96EA26Q53463213-FCC8B60C-2F8E-441A-9A19-86D27D26877CQ55317350-BDB9BDAC-0EA1-460B-B636-45AC93365D2EQ56975168-8E7AA12E-E139-4FE7-A6D9-550576701715Q57161239-5EB5C495-AD77-4536-BFC5-423EBBF480EC
P2860
Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolution and pharmacological ...... in canine pulmonary vein model
@en
Evolution and pharmacological ...... n canine pulmonary vein model.
@nl
type
label
Evolution and pharmacological ...... in canine pulmonary vein model
@en
Evolution and pharmacological ...... n canine pulmonary vein model.
@nl
prefLabel
Evolution and pharmacological ...... in canine pulmonary vein model
@en
Evolution and pharmacological ...... n canine pulmonary vein model.
@nl
P2093
P2860
P356
P1433
P1476
Evolution and pharmacological ...... in canine pulmonary vein model
@en
P2093
Henggui Zhang
Jules C Hancox
Oleg V Aslanidi
P2860
P304
P356
10.1093/EUROPACE/EUT349
P577
2014-03-01T00:00:00Z